17-36943007-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005568.5(LHX1):āc.1097A>Gā(p.His366Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000102 in 1,609,634 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 32)
Exomes š: 0.00011 ( 1 hom. )
Consequence
LHX1
NM_005568.5 missense
NM_005568.5 missense
Scores
2
1
12
Clinical Significance
Conservation
PhyloP100: 6.23
Genes affected
LHX1 (HGNC:6593): (LIM homeobox 1) This gene encodes a member of a large protein family which contains the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein is a transcription factor important for the development of the renal and urogenital systems. This gene is a candidate for Mayer-Rokitansky-Kuster-Hauser syndrome, a disorder characterized by anomalies in the female genital tract. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.05770713).
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHX1 | NM_005568.5 | c.1097A>G | p.His366Arg | missense_variant | 5/5 | ENST00000614239.1 | NP_005559.2 | |
LHX1 | XM_047435966.1 | c.1097A>G | p.His366Arg | missense_variant | 6/6 | XP_047291922.1 | ||
LHX1 | XM_047435967.1 | c.1097A>G | p.His366Arg | missense_variant | 6/6 | XP_047291923.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHX1 | ENST00000614239.1 | c.1097A>G | p.His366Arg | missense_variant | 5/5 | 1 | NM_005568.5 | ENSP00000477829.1 | ||
LHX1 | ENST00000621767.1 | c.68-235A>G | intron_variant | 2 | ENSP00000481496.1 | |||||
ENSG00000276707 | ENST00000614759.1 | n.367+83T>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151200Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
151200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000132 AC: 32AN: 241834Hom.: 0 AF XY: 0.000196 AC XY: 26AN XY: 132744
GnomAD3 exomes
AF:
AC:
32
AN:
241834
Hom.:
AF XY:
AC XY:
26
AN XY:
132744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 159AN: 1458434Hom.: 1 Cov.: 34 AF XY: 0.000149 AC XY: 108AN XY: 725228
GnomAD4 exome
AF:
AC:
159
AN:
1458434
Hom.:
Cov.:
34
AF XY:
AC XY:
108
AN XY:
725228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151200Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73778
GnomAD4 genome
AF:
AC:
5
AN:
151200
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
73778
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
22
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2022 | The c.1097A>G (p.H366R) alteration is located in exon 5 (coding exon 5) of the LHX1 gene. This alteration results from a A to G substitution at nucleotide position 1097, causing the histidine (H) at amino acid position 366 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L
PrimateAI
Pathogenic
D
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of methylation at H366 (P = 0.1117);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at